拒还2.24亿美元预付款,中国Biotech凭什么?

动脉新医药
25 Mar

3月24日,三叶草生物发布公告,其全资附属公司三叶草香港,收到全球疫苗免疫联盟(Gavi)发出的,日期为2025年3月21日的,提前一个月的书面通知。该通知声称,Gavi单方面终止预购协议,以及日期为2025年3月21日的索偿函,该函件要求三叶草香港退还预付款项2.24亿美元(“预付款金额”)。三叶草生物公告表示,公司拒绝有关退款的要求,认为基于预购协议条款该等要求缺乏依据,并将全力以赴、严正有力...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10